We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Anthocyans on Cardiovascular and Sympathetic Function

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00634387
First Posted: March 13, 2008
Last Update Posted: July 6, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
MedPalett
Information provided by:
Oslo University Hospital
  Purpose
Anthocyans modify cardiovascular and sympathetic function

Condition Intervention
Hypertension Dietary Supplement: Anthocyans Other: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Anthocyans on Cardiovascular and Sympathetic Function

Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Systolic bloodpressure and heartrate

Enrollment: 27
Study Start Date: March 2008
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: A
Anthocyans
Dietary Supplement: Anthocyans
Anthocyans
Dietary Supplement: Anthocyans
Placebo Comparator: B
no effective agent
Dietary Supplement: Anthocyans
Anthocyans
Other: placebo

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ages 35 to 50 years old
  • Males
  • Hypertension
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00634387


Locations
Norway
Cardiovascular and Renal Research Center, Ulleval University Hospital
Oslo, Norway, 0407
Sponsors and Collaborators
Ullevaal University Hospital
MedPalett
  More Information

Responsible Party: Morten Rostrup MD PhD, Ullevaal University Hospital
ClinicalTrials.gov Identifier: NCT00634387     History of Changes
Other Study ID Numbers: AC2008
First Submitted: March 5, 2008
First Posted: March 13, 2008
Last Update Posted: July 6, 2011
Last Verified: February 2010